MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..8 of 8 - per page
Order by
pH maintenance, Spermicide, Microbicide Lubricant More
Hyaluronan based gel for prevention and reduction of adhesion formation in the abdominal pelvic area More
Superior Alternative to Pads and Tampons More
A non-invasive development of a test for the diagnosis and monitoring of endometriosis. More
The primary function of ADAMTS-2 is the maturation of procollagen type I, II and III. Results obtained by in vitro testing, ex vivo model, and in vivo model support the hypothesis that ADAMTS-2 is an anti-angiogenic factor. More
This technology involves a validated, enzyme linked immunosorbent assay (ELISA) with a chemiluminescence readout, using commercially available antibodies to quantitate total TopoI from cell and tumor extracts. More
Name of the inventor: Joyce Lustbader Synthetic FSH which exhibit increased serum half –life when compared to FSH are described. FSH analogues can be expressed as single chain polypeptides having both the .alpha. and .beta. subunits of FSH and a... More
Name of the inventor: Joyce Lustbader Compositions containing vascular endothelial growth factor-follicle stimulating hormone (VEGF-FSH) compounds where VEGF-FSH compounds have increased serum half-lives relative to either native VEGF or FSH, are... More
Displaying 1..8 of 8 - per page
Order by

Your selection

Therapeutic target
Genito-urinary del
Genito-urinary other del
Infertility del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us